Insider Transactions in Q4 2024 at Crispr Therapeutics Ag (CRSP)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 24
2024
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,751
+6.58%
|
$220,016
$16.21 P/Share
|
|
Dec 02
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,000
-7.63%
|
$825,000
$55.1 P/Share
|
|
Nov 11
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,000
-6.79%
|
$1,650,000
$55.85 P/Share
|
|
Oct 14
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,293
-1.86%
|
$197,478
$46.28 P/Share
|
|
Oct 14
2024
|
James R. Kasinger General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
1,089
-1.71%
|
$50,094
$46.28 P/Share
|
|
Oct 13
2024
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,333
+3.48%
|
-
|
|
Oct 13
2024
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,113
+3.21%
|
-
|